<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Lock-and-Key on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/lock-and-key/</link>
    <description>Recent content in Lock-and-Key on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 25 Feb 2026 22:40:16 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/lock-and-key/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>&#39;Lock-and-key&#39; chemistry keeps cancer drugs inactive until they reach tumor sites</title>
      <link>https://cluster-site.onrender.com/posts/lock-and-key-chemistry-keeps-cancer-drugs-inactive-until-they-reach-tumor-sites/</link>
      <pubDate>Wed, 25 Feb 2026 22:32:37 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/lock-and-key-chemistry-keeps-cancer-drugs-inactive-until-they-reach-tumor-sites/</guid>
      <description>• Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant side effects • This creates a critical need for strat</description>
    </item>
  </channel>
</rss>
